PPH Legal Blog

Lannett Inc, a pharmaceutical company, has received approval from the FDA to go ahead and market Phentermine Hydrochloride. They received approval via their Abbreviated New Drug Application.

Phentermine Hydrochloride is intended to be a treatment option in the battle against obesity. Lannett hopes to begin selling their product as soon as possible.

Phentermine is by no means a new drug. It originally had approval in the 1950s and was part of the recalled diet drug fen-phen.  Fen-phen was recalled after it was linked to Primary Pulmonary Hypertension.

If you or someone you know has been diagnosed with Primary Pulmonary Hypertension (PPH), contact the PPH Lawsuit Attorneys of Williams Kherkher at 1-866-950-9000 to discuss your legal options and to schedule a free initial consultation.